Clinical Trials Directory

Trials / Completed

CompletedNCT01950416

Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Post Fibrinolysis

Pharmacodynamic Assessment of Ticagrelor vs High Dose Clopidogrel in Patients With ST Elevation Myocardial Infarction Exhibiting High Platelet Reactivity Post Fibrinolysis

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
56 (actual)
Sponsor
University of Patras · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This is a two-center, prospective, randomized, single-blind, investigator initiated, pharmacodynamic study of parallel design, carried out in 2 PCI-capable cardiology centers (Patras University Hospital and Konstantopoulio General Hospital of Athens). Patients with ST elevation myocardial infarction, having undergone fibrinolysis in the previous 3 to 48 hours, who present high residual PR (defined as PRU ≥208 ) on admission, pre coronary angiography, will be randomized after written informed consent, in a 1:1 ratio to either: Ticagrelor 180mg loading dose (LD), followed by a 90mg x2 maintenance dose (MD) starting 12±6 hours post LD, until discharge. Or Clopidogrel 600mg loading dose (LD), followed by a 150mg once daily maintenance dose (MD) starting 12±6 hours post LD, until discharge. Platelet reactivity assessment will be performed at randomization (Hour 0) and at 2, 24 hours after randomization, as well as pre-discharge, using the VerifyNow assay, in platelet reactivity units (PRU). Documentation of major adverse cardiac events (death, myocardial infarction, stroke, ischemia driven revascularization procedure with PCI or CABG) and bleeding (according to BARC criteria) will be performed until patient's discharge.

Conditions

Interventions

TypeNameDescription
DRUGTicagrelor 180mg loading dose and 90mg bid maintenance dose
DRUGClopidogrel 600mg loading dose and 150mg maintenance dose

Timeline

Start date
2013-03-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2013-09-25
Last updated
2015-08-20

Locations

2 sites across 1 country: Greece

Source: ClinicalTrials.gov record NCT01950416. Inclusion in this directory is not an endorsement.